681 results on '"Satoskar"'
Search Results
2. The Diagnostic Conundrum of Glomerular Crescents With IgA Deposits
- Author
-
Mineaki Kitamura, Salem Almaani, Bindu Challa, Mohankumar Doraiswamy, Isabelle Ayoub, Laura Biederman, Samir V. Parikh, Ana Molovic-Kokovic, Jason Benedict, Nilesh Mhaskar, Zeid J. Khitan, Sergey V. Brodsky, Tibor Nadasdy, and Anjali A. Satoskar
- Subjects
Nephrology - Published
- 2023
3. Bridging and downstaging with <scp>TACE</scp> in early and intermediate stage hepatocellular carcinoma: Predictors of receiving a liver transplant
- Author
-
Chao Yin, Samantha Armstrong, Richard Shin, Xue Geng, Hongkun Wang, Rohit S. Satoskar, Thomas Fishbein, Coleman Smith, Filip Banovac, Alexander Y. Kim, and Aiwu Ruth He
- Subjects
Gastroenterology ,Surgery - Published
- 2022
4. Triple hit to the kidney-dual pathological crescentic glomerulonephritis and diffuse proliferative immune complex-mediated glomerulonephritis: A case report
- Author
-
Dalia Ibrahim, Sergey V Brodsky, Anjali A Satoskar, Laura Biederman, and Natallia Maroz
- Subjects
General Medicine - Published
- 2022
5. Transdermal delivery via medical device technologies
- Author
-
Shubhangi, Shukla, Ryan H, Huston, Blake D, Cox, Abhay R, Satoskar, and Roger J, Narayan
- Subjects
Drug Delivery Systems ,Pharmaceutical Preparations ,Technology, Pharmaceutical ,Pharmaceutical Science ,Administration, Cutaneous ,Lipids - Abstract
Despite their effectiveness and indispensability, many drugs are poorly solvated in aqueous solutions. Over recent decades, the need for targeted drug delivery has led to the development of pharmaceutical formulations with enhanced lipid solubility to improve their delivery properties. Therefore, a dependable approach for administering lipid-soluble drugs needs to be developed.The advent of 3D printing or additive manufacturing (AM) has revolutionized the development of medical devices, which can effectively enable the delivery of lipophilic drugs to the targeted tissues. This review focuses on the use of microneedles and iontophoresis for transdermal drug delivery. Microneedle arrays, inkjet printing, and fused deposition modeling have emerged as valuable approaches for delivering several classes of drugs. In addition, iontophoresis has been successfully employed for the effective delivery of macromolecular drugs.Microneedle arrays, inkjet printing, and fused deposition are potentially useful for many drug delivery applications; however, the clinical and commercial adoption rates of these technologies are relatively low. Additional efforts is needed to enable the pharmaceutical community to fully realize the benefits of these technologies.
- Published
- 2022
6. Genomic Study on Blood Culture Isolates From Patients With Staphylococcus Infection-associated Glomerulonephritis
- Author
-
Pranav S.J.B. Rana, Jihad Aljabban, Melanie Prarat, Preeti Pancholi, Joan Miquel Balada-Llasat, Julie Stephens, Amy Webb, Liang Chen, Sergey V. Brodsky, Tibor Nadasdy, Yan Zhang, Samir V. Parikh, Daniel J. Wozniak, Shu-Hua Wang, Michael Olson, and Anjali A. Satoskar
- Subjects
Nephrology - Published
- 2022
7. Postoperative Myocardial Injury and Outcomes in Liver and Kidney Transplant Patients
- Author
-
Michael, Yang, Syed Z, Qamer, Andrew P, Hill, Brian C, Case, Alexander J, Gilbert, Rohit S, Satoskar, Alexander T, Lalos, Carolina, Valdiviezo, Toby, Rogers, Lowell F, Satler, Ron, Waksman, and Itsik, Ben-Dor
- Subjects
Postoperative Complications ,Heart Injuries ,Risk Factors ,Myocardial Infarction ,Humans ,Prospective Studies ,General Medicine ,Middle Aged ,Cardiology and Cardiovascular Medicine ,Kidney Transplantation ,Troponin ,Liver Transplantation ,Retrospective Studies - Abstract
Myocardial injury after noncardiac surgery (MINS) is associated with major adverse cardiac events (MACE), but its significance post-liver and post-kidney transplantation is not well-defined.We retrospectively studied consecutive patients undergoing single-organ liver or kidney transplantation at a large tertiary transplant center. Liver and kidney transplant patients with troponins drawn within 30 days of transplantation were included. The primary exposure was MINS, defined as troponin elevation above the 99th percentile of the upper reference limit within 30 days of transplantation. The primary outcome was MACE, defined as death, myocardial infarction, revascularization, stroke, or heart failure hospitalization.Overall, 112 patients were included: 58 (51.7%) were liver transplant recipients, and 54 (48.3%) were kidney transplant recipients. Patients with MINS were significantly older (mean age 59 vs. 54 years, p = 0.01) and more likely to have diabetes (35% vs. 17%, p = 0.03). Other baseline characteristics were similar. Sixteen patients (14.2%) developed MACE, including 11 (9.8%) with 1-year MACE. MINS patients were significantly more likely to develop 1-year MACE (adjusted hazard ratio, 10.4; 95% confidence interval, 1.8-198). Kaplan-Meier cumulative MACE was significantly higher in the MINS group (p = 0.03).Liver and kidney transplant recipients with MINS are significantly more likely to develop 1-year MACE compared to those without MINS. Future prospective studies are needed to further delineate the cardiac risk and outcomes in transplanted patients.
- Published
- 2022
8. Antibody-suppressor CXCR5+CD8+ T cellular therapy ameliorates antibody-mediated rejection following kidney transplant in CCR5 KO mice
- Author
-
Jason M. Zimmerer, Jing L. Han, Chelsea M. Peterson, Qiang Zeng, Bryce A. Ringwald, Clarissa Cassol, Sachi Chaudhari, Madison Hart, Jessica Hemminger, Anjali Satoskar, Mahmoud Abdel-Rasoul, Jiao-Jing Wang, Robert T. Warren, Zheng J. Zhang, Christopher K. Breuer, and Ginny L. Bumgardner
- Subjects
Graft Rejection ,Mice, Inbred C57BL ,Mice, Knockout ,Mice ,Transplantation ,Isoantibodies ,Immunoglobulin G ,Animals ,Immunology and Allergy ,Pharmacology (medical) ,CD8-Positive T-Lymphocytes ,Kidney Transplantation ,Article - Abstract
CCR5 KO kidney transplant (KTx) recipients are extraordinarily high alloantibody producers and develop pathology that mimics human antibody-mediated rejection (AMR). C57BL/6 and CCR5 KO mice (H-2(b)) were transplanted with A/J kidneys (H-2(a)); select cohorts received adoptive cell therapy (ACT) with alloprimed CXCR5(+)CD8(+) T cells (or control cells) on day 5 after KTx. ACT efficacy was evaluated by measuring posttransplant alloantibody, pathology, and allograft survival. Recipients were assessed for quantity of CXCR5(+)CD8(+) T cells and CD8-mediated cytotoxicity to alloprimed IgG(+) B cells. Alloantibody titer in CCR5 KO recipients was four-fold higher than in C57BL/6 recipients. The proportion of alloprimed CXCR5(+)CD8(+) T cells 7 days after KTx in peripheral blood, lymph node, and spleen was substantially lower in CCR5 KO compared to C57BL/6 recipients. In vivo cytotoxicity towards alloprimed IgG(+) B cells was also reduced six-fold in CCR5 KO recipients. ACT with alloprimed CXCR5(+)CD8(+) T cells (but not alloprimed CXCR5(−)CD8(+) or third-party primed CXCR5(+)CD8(+) T cells) substantially reduced alloantibody titer, ameliorated AMR pathology, and prolonged allograft survival. These results indicate that a deficiency in quantity and function of alloprimed CXCR5(+)CD8(+) T cells contributes to high alloantibody and AMR in CCR5 KO recipient mice, which can be rescued with ACT.
- Published
- 2022
9. Immunization with a Trypanosoma cruzi cyclophilin-19 deletion mutant protects against acute Chagas disease in mice
- Author
-
Bijay Kumar Jha, Sanjay Varikuti, Chaitenya Verma, Rahul Shivahare, Nicholas Bishop, Gregory P. Dos Santos, Jacquelyn McDonald, Aakash Sur, Peter J. Myler, Sergio Schenkman, Abhay R. Satoskar, and Bradford S. McGwire
- Subjects
Pharmacology ,Infectious Diseases ,Immunology ,Pharmacology (medical) - Abstract
Human infection with the protozoan parasite Trypanosoma cruzi causes Chagas disease for which there are no prophylactic vaccines. Cyclophilin 19 is a secreted cis-trans peptidyl isomerase expressed in all life stages of Trypanosoma cruzi. This protein in the insect stage leads to the inactivation of insect anti-parasitic peptides and parasite transformation whereas in the intracellular amastigotes it participates in generating ROS promoting the growth of parasites. We have generated a parasite mutant with depleted expression of Cyp19 by removal of 2 of 3 genes encoding this protein using double allelic homologous recombination. The mutant parasite line failed to replicate when inoculated into host cells in vitro or in mice indicating that Cyp19 is critical for infectivity. The mutant parasite line also fails to replicate in or cause clinical disease in immuno-deficient mice further validating their lack of virulence. Repeated inoculation of mutant parasites into immuno-competent mice elicits parasite-specific trypanolytic antibodies and a Th-1 biased immune response and challenge of mutant immunized mice with virulent wild-type parasites is 100% effective at preventing death from acute disease. These results suggest that parasite Cyp19 may be candidate for small molecule drug targeting and that the mutant parasite line may warrant further immunization studies for prevention of Chagas disease.
- Published
- 2023
10. Supplementary Figure 4 from Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
- Author
-
Aiwu Ruth He, Michael Atkins, Louis Weiner, John Marshall, Christopher Loffredo, Petra Prins, Anteneh Tesfaye, Tiger Zhang, Perry Feng, Jaydeep Kachhela, Reena Jha, Filip Banovac, Rohit Satoskar, Eddie Island, Lynt Johnson, Thomas Fishbein, David Kleiner, Sandeep Reddy, Zoran Gatalica, Bhaskar Kallakury, Jiji Jiang, Hongkun Wang, Yunan Wu, and Andrew Gabrielson
- Abstract
Graphical distributions of CD3+ and CD8+ T lymphocyte densities in the TI and IM.
- Published
- 2023
11. Supplementary Figure 3 from Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
- Author
-
Aiwu Ruth He, Michael Atkins, Louis Weiner, John Marshall, Christopher Loffredo, Petra Prins, Anteneh Tesfaye, Tiger Zhang, Perry Feng, Jaydeep Kachhela, Reena Jha, Filip Banovac, Rohit Satoskar, Eddie Island, Lynt Johnson, Thomas Fishbein, David Kleiner, Sandeep Reddy, Zoran Gatalica, Bhaskar Kallakury, Jiji Jiang, Hongkun Wang, Yunan Wu, and Andrew Gabrielson
- Abstract
ImageJ plug-in code for image analysis.
- Published
- 2023
12. Supplementary Figure 5 from Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
- Author
-
Aiwu Ruth He, Michael Atkins, Louis Weiner, John Marshall, Christopher Loffredo, Petra Prins, Anteneh Tesfaye, Tiger Zhang, Perry Feng, Jaydeep Kachhela, Reena Jha, Filip Banovac, Rohit Satoskar, Eddie Island, Lynt Johnson, Thomas Fishbein, David Kleiner, Sandeep Reddy, Zoran Gatalica, Bhaskar Kallakury, Jiji Jiang, Hongkun Wang, Yunan Wu, and Andrew Gabrielson
- Abstract
Bivariate analysis of TIL pattern and tumor stage, cellular differentiation, and vascular invasion.
- Published
- 2023
13. Data from Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
- Author
-
Aiwu Ruth He, Michael Atkins, Louis Weiner, John Marshall, Christopher Loffredo, Petra Prins, Anteneh Tesfaye, Tiger Zhang, Perry Feng, Jaydeep Kachhela, Reena Jha, Filip Banovac, Rohit Satoskar, Eddie Island, Lynt Johnson, Thomas Fishbein, David Kleiner, Sandeep Reddy, Zoran Gatalica, Bhaskar Kallakury, Jiji Jiang, Hongkun Wang, Yunan Wu, and Andrew Gabrielson
- Abstract
Immune cells that infiltrate a tumor may be a prognostic factor for patients who have had surgically resected hepatocellular carcinoma (HCC). The density of intratumoral total (CD3+) and cytotoxic (CD8+) T lymphocytes was measured in the tumor interior and in the invasive margin of 65 stage I to IV HCC tissue specimens from a single cohort. Immune cell density in the interior and margin was converted to a binary score (0, low; 1, high), which was correlated with tumor recurrence and relapse-free survival (RFS). In addition, the expression of programmed death 1 (PD-1) and programmed death ligand 1 (PD-L1) was correlated with the density of CD3+ and CD8+ cells and clinical outcome. High densities of both CD3+ and CD8+ T cells in both the interior and margin, along with corresponding Immunoscores, were significantly associated with a low rate of recurrence (P = 0.007) and a prolonged RFS (P = 0.002). In multivariate logistic regression models adjusted for vascular invasion and cellular differentiation, both CD3+ and CD8+ cell densities predicted recurrence, with odds ratios of 5.8 [95% confidence interval (CI), 1.6–21.8] for CD3+ and 3.9 (95% CI, 1.1–14.1) for CD8+. Positive PD-L1 staining was correlated with high CD3 and CD8 density (P = 0.024 and 0.005, respectively) and predicted a lower rate of recurrence (P = 0.034), as well as prolonged RFS (P = 0.029). Immunoscore and PD-L1 expression, therefore, are useful prognostic markers in patients with HCC who have undergone primary tumor resection. Cancer Immunol Res; 4(5); 419–30. ©2016 AACR.
- Published
- 2023
14. Supplementary Figure 6 from Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
- Author
-
Aiwu Ruth He, Michael Atkins, Louis Weiner, John Marshall, Christopher Loffredo, Petra Prins, Anteneh Tesfaye, Tiger Zhang, Perry Feng, Jaydeep Kachhela, Reena Jha, Filip Banovac, Rohit Satoskar, Eddie Island, Lynt Johnson, Thomas Fishbein, David Kleiner, Sandeep Reddy, Zoran Gatalica, Bhaskar Kallakury, Jiji Jiang, Hongkun Wang, Yunan Wu, and Andrew Gabrielson
- Abstract
Kaplan-Meier analysis of RFS stratified by pattern of CD3+ and CD8+ T lymphocytes.
- Published
- 2023
15. Supplementary Figure 2 from Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
- Author
-
Aiwu Ruth He, Michael Atkins, Louis Weiner, John Marshall, Christopher Loffredo, Petra Prins, Anteneh Tesfaye, Tiger Zhang, Perry Feng, Jaydeep Kachhela, Reena Jha, Filip Banovac, Rohit Satoskar, Eddie Island, Lynt Johnson, Thomas Fishbein, David Kleiner, Sandeep Reddy, Zoran Gatalica, Bhaskar Kallakury, Jiji Jiang, Hongkun Wang, Yunan Wu, and Andrew Gabrielson
- Abstract
Example of computer-assisted evaluation of infiltrate densities.
- Published
- 2023
16. Supplementary Figure 7 from Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
- Author
-
Aiwu Ruth He, Michael Atkins, Louis Weiner, John Marshall, Christopher Loffredo, Petra Prins, Anteneh Tesfaye, Tiger Zhang, Perry Feng, Jaydeep Kachhela, Reena Jha, Filip Banovac, Rohit Satoskar, Eddie Island, Lynt Johnson, Thomas Fishbein, David Kleiner, Sandeep Reddy, Zoran Gatalica, Bhaskar Kallakury, Jiji Jiang, Hongkun Wang, Yunan Wu, and Andrew Gabrielson
- Abstract
Bivariate analysis of CD3+ and CD8+ cell density and beta-catenin expression.
- Published
- 2023
17. Supplementary Figure 1 from Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
- Author
-
Aiwu Ruth He, Michael Atkins, Louis Weiner, John Marshall, Christopher Loffredo, Petra Prins, Anteneh Tesfaye, Tiger Zhang, Perry Feng, Jaydeep Kachhela, Reena Jha, Filip Banovac, Rohit Satoskar, Eddie Island, Lynt Johnson, Thomas Fishbein, David Kleiner, Sandeep Reddy, Zoran Gatalica, Bhaskar Kallakury, Jiji Jiang, Hongkun Wang, Yunan Wu, and Andrew Gabrielson
- Abstract
Flowchart of image analysis process.
- Published
- 2023
18. Supplementary Figure 8 from Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
- Author
-
Aiwu Ruth He, Michael Atkins, Louis Weiner, John Marshall, Christopher Loffredo, Petra Prins, Anteneh Tesfaye, Tiger Zhang, Perry Feng, Jaydeep Kachhela, Reena Jha, Filip Banovac, Rohit Satoskar, Eddie Island, Lynt Johnson, Thomas Fishbein, David Kleiner, Sandeep Reddy, Zoran Gatalica, Bhaskar Kallakury, Jiji Jiang, Hongkun Wang, Yunan Wu, and Andrew Gabrielson
- Abstract
Bivariate analysis of tumor stage with vascular invasion and cellular differentiation.
- Published
- 2023
19. Clinical Outcomes in Patients With Biopsy Proven Anticoagulant-Related Nephropathy
- Author
-
Alana Dasgupta, Galina Mikhalina, Anjali A. Satoskar, Laura Biederman, Tibor Nadasdy, Brad Rovin, Samir Parikh, and Sergey V. Brodsky
- Subjects
Nephrology - Published
- 2023
20. Supplementary Figure 1-12 from A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2
- Author
-
S. Perwez Hussain, H. Richard Alexander, Nader Hanna, Thomas Ried, Jens Werner, Frank Bergmann, Matthias M. Gaida, B. Michael Ghadimi, Markus Bernhardt, Jochen Gaedcke, Abhay R. Satoskar, Tadashi Uwagawa, Katsuhiko Yanaga, Naotake Funamizu, Wei Tang, Aaron Schetter, Jian Wang, Peijun He, and Shouhui Yang
- Abstract
Figure S1. Validation of miRNA microarray data by qRT-PCR in the test cohort (n=69). Figure S2. MIF regulates miR-301b expression in human pancreatic cancer Figure S3. NR3C2 is a potential target of miR-301b. Figure S4. Endogenous NR3C2 expression was negatively correlated with MIF and miR-301b in a panel of human pancreatic cancer cell lines. Figure S5. NR3C2 enhances sensitivity to gemcitabine in pancreatic cancer cell lines. Figure S6. Knockdown of NR3C2 increases proliferation, migration and invasion, and decreases sensitivity of pancreatic cancer cells to gemcitabine. Figure S7. A lower endogenous NR3C2 expression was associated with EMT phenotype. Figure S8. NR3C2 inhibits epithelial-to-mesenchymal transition (EMT). Figure S9. MIF-induced miR-301b expression was blocked by anti-miR-301b. Figure S10. MEK inhibitor AZD6244 didn't alter miR-301b or NR3C2 in MIF-overexpressing Panc-1 and Capan-2 cells. Figure S11. NR3C2 expression is decreased in tumors as compared to adjacent nontumor tissues in PDAC. Figure S12. A lower expression of NR3C2 is associated with poor survival in multiple independent cohorts of PDAC.
- Published
- 2023
21. Supplementary Information from A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2
- Author
-
S. Perwez Hussain, H. Richard Alexander, Nader Hanna, Thomas Ried, Jens Werner, Frank Bergmann, Matthias M. Gaida, B. Michael Ghadimi, Markus Bernhardt, Jochen Gaedcke, Abhay R. Satoskar, Tadashi Uwagawa, Katsuhiko Yanaga, Naotake Funamizu, Wei Tang, Aaron Schetter, Jian Wang, Peijun He, and Shouhui Yang
- Abstract
Supplementary Materials and Methods and Supplementary Figure Legends
- Published
- 2023
22. Supplementary Tables S1-S9 from A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2
- Author
-
S. Perwez Hussain, H. Richard Alexander, Nader Hanna, Thomas Ried, Jens Werner, Frank Bergmann, Matthias M. Gaida, B. Michael Ghadimi, Markus Bernhardt, Jochen Gaedcke, Abhay R. Satoskar, Tadashi Uwagawa, Katsuhiko Yanaga, Naotake Funamizu, Wei Tang, Aaron Schetter, Jian Wang, Peijun He, and Shouhui Yang
- Abstract
Table S1. Characteristics of Patients' Population (Test cohort, N=69). Table S2. Characteristics of Patients' Population (Validation Cohort-1, N=41). Table S3. Characteristics of Patients' Population (Validation Cohort-2, N=64). Table S4. Clinicopathologic features of TCGA cohort. Table S5. Characteristics of tissue microarray cohort (Validation cohort-3, N=173) Table S6. Differentially expressed miRNAs in MIF-High and MIF-Low PDAC cases and their association with survival (cox regression). Table S7. miR-301b candidate target gene associated with survival by Cox regression and Kaplan-Meier analyses. Table S8. qRT-PCR probes and primer sequences for plasmid construction. Table S9. Antibodies information
- Published
- 2023
23. STAT1 is regulated by TRIM24 and promotes immunosuppression in head and neck squamous carcinoma cells, but enhances T cell antitumour immunity in the tumour microenvironment
- Author
-
Kelvin Anderson, Nathan Ryan, Divya Nedungadi, Felipe Lamenza, Michael Swingler, Arham Siddiqui, Abhay Satoskar, Puja Upadhaya, Maciej Pietrzak, and Steve Oghumu
- Subjects
Immunosuppression Therapy ,Cancer Research ,Carcinogenesis ,Squamous Cell Carcinoma of Head and Neck ,B7-H1 Antigen ,Mice ,STAT1 Transcription Factor ,Oncology ,Head and Neck Neoplasms ,Cell Line, Tumor ,Tumor Microenvironment ,Animals ,Humans ,Carrier Proteins - Abstract
Background Head and neck squamous cell carcinoma (HNSCC) is a significant problem and is frequently resistant to current treatments. STAT1 is important in anti-tumour immune responses against HNSCC. However, the role of STAT1 expression by tumour cells and its regulation during HNSCC is unclear. Methods We determined the effects of STAT1 inhibition on tumour development and immunity in CAL27 and UMSCC22A HNSCC cell lines in vitro and in a HNSCC carcinogen-induced model in vivo. Results STAT1 siRNA knockdown in human HNSCC cells impaired their proliferation and expression of the immunosuppressive marker PD-L1. Stat1-deficient mice displayed increased oral lesion incidence and multiplicity during tumour carcinogenesis in vivo. Immunosuppressive markers PD-1 in CD8+ T cells and PD-L1 in monocytic MDSCs and macrophages were reduced in oral tumours and draining lymph nodes of tumour-bearing Stat1-deficient mice. However, STAT1 was required for anti-tumour functions of T cells during HNSCC in vivo. Finally, we identified TRIM24 to be a negative regulator of STAT1 that plays a similar tumorigenic function to STAT1 in vitro and thus may be a potential target when treating HNSCC. Conclusion Our findings indicate that STAT1 activity plays an important role in tumorigenicity and immunosuppression during HNSCC development.
- Published
- 2022
24. Acute kidney injury and proteinuria in a patient with remote liver transplant: what is the cause? A nephrology quiz
- Author
-
Dalia Y. Ibrahim, Shyam Parkhie, and Anjali A. Satoskar
- Subjects
Nephrology - Published
- 2022
25. Casemix, management, and mortality of patients receiving emergency neurosurgery for traumatic brain injury in the Global Neurotrauma Outcomes Study: a prospective observational cohort study
- Author
-
David Clark, Alexis Joannides, Amos Olufemi Adeleye, Abdul Hafid Bajamal, Tom Bashford, Hagos Biluts, Karol Budohoski, Ari Ercole, Rocío Fernández-Méndez, Anthony Figaji, Deepak Kumar Gupta, Roger Härtl, Corrado Iaccarino, Tariq Khan, Tsegazeab Laeke, Andrés Rubiano, Hamisi K Shabani, Kachinga Sichizya, Manoj Tewari, Abenezer Tirsit, Myat Thu, Manjul Tripathi, Rikin Trivedi, Bhagavatula Indira Devi, Franco Servadei, David Menon, Angelos Kolias, Peter Hutchinson, Ghayur Abbas, Omar Ibrahim Abdallah, Ahmed Abdel-Lateef, Khalif Abdifatah, Awfa Abdullateef, Ruvini Abeygunaratne, Mostafa Aboellil, Abass Adam, Robert Adams, Amos Adeleye, Augustine Adeolu, Novan Krisno Adji, Nur Afianti, Sudarsan Agarwal, Ifeanyi Kene Aghadi, Paúl Martín Méndez Aguilar, Syeda Rida Ahmad, Daniyal Ahmed, Nafees Ahmed, Haider Aizaz, Yunus Kuntawi Aji, Alex Alamri, Augusto Jacinto Mussindo Alberto, Luis Alcocer Alcocer, Lesly Gonzales Alfaro, Amro Al-Habib, Ahmad Alhourani, Syed Muhammad Rafay Ali, Fahad Alkherayf, Ahmed AlMenabbawy, Aliyah Alshareef, Muhammad Adil s/o Aminullah, Madeha Amjad, Robson Luis Oliveira de Amorim, Sathiaprabhu Anbazhagan, Almir Andrade, Waleed Antar, Theophilus T.K. Anyomih, Salah Aoun, Tedy Apriawan, Daniele Armocida, Paul Arnold, Miguel Arraez, Temesgen Assefa, Andres Asser, S.P. Athiththan, Deepal Attanayake, Maung Maung Aung, Allan Avi, Victor Enrique Antolinez Ayala, Mohammed Azab, Gaousul Azam, Mohd Azharuddin, Olukemi Badejo, Mohamed Badran, Azam Ali Baig, Rehman Ali Baig, Ankur Bajaj, Paul Baker, Renu Bala, Artur Balasa, Ross Balchin, James Balogun, Vin Shen Ban, Bharath Kumar Reddy Bandi, Soham Bandyopadhyay, Matthew Bank, Ernest Barthelemy, Mohammed Talha Bashir, Luciano Silveira Basso, Surajit Basu, Auricelio Batista, Marlies Bauer, Devi Bavishi, Abi Beane, Shmuel Bejell, Anteneh Belachew, Antonio Belli, Amani Belouaer, Najia El Abbadi Bendahane, Okanga Benjamin, Youssef Benslimane, Chaymae Benyaiche, Claudio Bernucci, Luigi Valentino Berra, Arnold Bhebe, Alexios Bimpis, Diana Blanaru, Jean Claude Bonfim, Luis A B Borba, Alp Ozgun Borcek, Erika Borotto, Ahmad Elmabri Mohammad Bouhuwaish, Facundo Bourilhon, Gioia Brachini, Joshua Breedon, Maximilian Broger, Giacoma Maria Floriana Brunetto, Placido Bruzzaniti, Natalia Budohoska, Hira Burhan, Maximiliano Luis Calatroni, Catherine Camargo, Pier Francesco Cappai, Salvatore Massimiliano Cardali, Ana M Castaño-Leon, David Cederberg, Mikel Celaya, Marco Cenzato, Lakshmi Madhavi Challa, Dhanny Charest, Bipin Chaurasia, Rabah Chenna, Iype Cherian, Juliana Henry Ching'o, Tejas Chotai, Ajay Choudhary, Nabeel Choudhary, Florence Choumin, Tomislav Cigic, Juan Ciro, Carlo Conti, Antônio Carlos de Souza Corrêa, Giulia Cossu, Maíra Piani Couto, Aurora Cruz, Divya D'Silva, Giuseppe Antonio D'Aliberti, Lamin Dampha, Roy Thomas Daniel, Andrew Dapaah, Aneela Darbar, Gabriel Dascalu, Happy Amos Dauda, Owain Davies, Andrea Delgado-Babiano, Markus Dengl, Marko Despotovic, Indira Devi, Celeste Dias, Mohamed Dirar, Melina Dissanayake, Hananiah Djimbaye, Simon Dockrell, Ali Dolachee, Julija Dolgopolova, Muge Dolgun, Abdalrouf Dow, Davide Drusiani, Artjom Dugan, Dinh Tuan Duong, Trung Kien Duong, Tomasz Dziedzic, Ali Ebrahim, Nizar El Fatemi, Antonios El El Helou, Rachid El El Maaqili, Brahim El El Mostarchid, Abdessamad El El Ouahabi, Mohammad Elbaroody, Ahmed El-Fiki, Ahmed El-Garci, Nasser M.F. El-Ghandour, Muhammed Elhadi, Vanessa Elleder, Safa Elrais, Mohamed El-shazly, Mohamed Elshenawy, Hesham Elshitany, Omar El-Sobky, Marwa Emhamed, Basil Enicker, Onur Erdogan, Sebastian Ertl, Ignatius Esene, Omar Ocampo Espinosa, Tarig Fadalla, Mohammed Fadelalla, Rodrigo Moreira Faleiro, Nida Fatima, Charbel Fawaz, Assefa Fentaw, Carla Eiriz Fernandez, Ana Ferreira, Francesco Ferri, Tony Figaji, Emerson L B Filho, Loic Fin, Benjamin Fisher, Fitra Fitra, Alexis Palpan Flores, Ioan Stefan Florian, Vincenzo Fontana, Lauren Ford, Daniel Fountain, Jose Maria Roda Frade, Antonio Fratto, Christian Freyschlag, Aranzazu Sánchez Gabin, Clare Gallagher, Mario Ganau, Maria Luisa Gandia-Gonzalez, Andoni Garcia, Borja Hernandez Garcia, Sanjeewa Garusinghe, Biniam Gebreegziabher, Adrian Gelb, Jerome St George, Antonino Francesco Germanò, Ilaria Ghetti, Prajwal Ghimire, Alessandro Giammarusti, Jose Luis Gil, Panagiota Gkolia, Yoseph Godebo, Prakash Rao Gollapudi, Jagos Golubovic, Jeremias Fernando Gomes, Javier Gonzales, William Gormley, Alexander Gots, Giulia Letizia Gribaudi, Dylan Griswold, Paolo Gritti, Ruan Grobler, Rudy Gunawan, Birhanu Hailemichael, Elmehdi Hakkou, Mark Haley, Alhafidz Hamdan, Ali Hammed, Waeel Hamouda, Nurul Ashikin Hamzah, Nyein Latt Han, Sahin Hanalioglu, Rashan Haniffa, Martin Hanko, John Hanrahan, Timothy Hardcastle, Fahd Derkaoui Hassani, Volkmar Heidecke, Eirik Helseth, Miguel Ángel Hernández-Hernández, Zachary Hickman, Le Minh Chau Hoang, Alexa Hollinger, Lenka Horakova, Kismet Hossain-Ibrahim, Boru Hou, Samer Hoz, Janine Hsu, Martin Hunn, Madiha Hussain, Giorgia Iacopino, Mylena Miki Lopes Ideta, Irene Iglesias, Ali Ilunga, Nafiz Imtiaz, Rafiza Islam, Serge Ivashchenko, Karim Izirouel, Mohamed Sobhi Jabal, Soubhi Jabal, John Nute Jabang, Aimun Jamjoom, Irfan Jan, Landing BM Jarju, Saad Javed, Bojan Jelaca, Sukhdeep Singh Jhawar, Ting Ting Jiang, Fernando Jimenez, Jorge Jiris, Ron Jithoo, Walt Johnson, Mathew Joseph, Rameshman Joshi, Eija Junttila, Mubashir Jusabani, Stephen Akau Kache, Satyavara Prasad Kadali, Gabriela F Kalkmann, Usman Kamboh, Hitham Kandel, Ahmet Kamil Karakus, Mengistu Kassa, Ari Katila, Yoko Kato, Martin Keba, Kristy Kehoe, Huseyin Hayri Kertmen, Soha Khafaji, Monty Khajanchi, Mohammed Khan, Muhammad Mukhtar Khan, Sohail Daud Khan, Ahtesham Khizar, Amir Khriesh, Sara Kierońska, Paul Kisanga, Boniface Kivevele, Kacper Koczyk, Anna-Lucia Koerling, Danielle Koffenberger, Kennet Kõiv, Leho Kõiv, Branislav Kolarovszki, Marton König, Dilek Könü-Leblebicioglu, Santhoshi Devi Koppala, Tommi Korhonen, Boguslaw Kostkiewicz, Kacper Kostyra, Srinivas Kotakadira, Arjun Reddy Kotha, Madhu Narayana Rao Kottakki, Nenad Krajcinovic, Michal Krakowiak, Andreas Kramer, Selvamuthukumaran Krishnamoorthy, Ashok Kumar, Pankaj Kumar, Pradhumna Kumar, Nilaksha Kumarasinghe, Gowtham Kuncha, Raja K. Kutty, Ghazwan Lafta, Simon Lammy, Pierfrancesco Lapolla, Jacopo Lardani, Nebojsa Lasica, Giancarlo Lastrucci, Yoann Launey, Laura Lavalle, Tim Lawrence, Albert Lazaro, Vitalii Lebed, Ville Leinonen, Lawrence Lemeri, Leon Levi, Jia Yi Lim, Xiao Yi Lim, Jorge Linares-Torres, Laura Lippa, Lurdes Lisboa, Jinfang Liu, Ziyuan Liu, William B Lo, Jan Lodin, Federico Loi, Daniella Londono, Pedro Antonio Gomez Lopez, Cristina Barceló López, Madeleine De Lotbiniere-Bassett, Rihards Lulens, Facundo Hector Luna, Teemu Luoto, Vijaya Sekhar M.V., Ndyebo Mabovula, Matthew MacAllister, Alcina Americo Macie, Rodolfo Maduri, Moufid Mahfoud, Ashraf Mahmood, Fathia Mahmoud, Dominic Mahoney, Wissam Makhlouf, George Malcolm, Adefolarin Malomo, Toluyemi Malomo, Manoranjitha Kumari Mani, Tomás Gazzinelli Marçal, Jacopo Marchello, Nicolò Marchesini, Franz Marhold, Niklas Marklund, Rubén Martín-Láez, Vickneswaran Mathaneswaran, David José Mato-Mañas, Helen Maye, Aaron Lawson McLean, Catherine McMahon, Saniya Mediratta, Mehreen Mehboob, Alisson Meneses, Nesrine Mentri, Hagos Mersha, Ana Milena Mesa, Cristy Meyer, Christopher Millward, Salomao Amone Mimbir, Andrea Mingoli, Parashruram Mishra, Tejesh Mishra, Basant Misra, Siddharth Mittal, Imran Mohammed, Ioana Moldovan, Masechaba Molefe, Alexis Moles, Preston Moodley, Mario Augusto Narváez Morales, Lucy Morgan, German Del Castillo Morillo, Wahab Moustafa, Nikolaos Moustakis, Salma Mrichi, Satya Shiva Munjal, Abdul-Jalilu Mohammed Muntaka, Denver Naicker, Paulo E H Nakashima, Pratap Kumar Nandigama, Samantha Nash, Ionut Negoi, Valetina Negoita, Samundra Neupane, Manh Hung Nguyen, Fajar Herbowo Niantiarno, Abbi Noble, Mohd Arman Muhamad Nor, Blazej Nowak, Andrei Oancea, Frazer O'Brien, Oghenekevwe Okere, Sandra Olaya, Leandro Oliveira, Louise Makarem Oliveira, Fatma Omar, Okezi Ononeme, René Opšenák, Simone Orlandini, Alrobah Osama, Dorcas Osei-Poku, Haytham Osman, Alvaro Otero, Malte Ottenhausen, Shuli Otzri, Oumaima Outani, Emmanuel Abem Owusu, Kevin Owusu-Agyemang, Ahmad Ozair, Baris Ozoner, Elli Paal, Mauro Sérgio Paiva, Wellingson Paiva, Sharad Pandey, Gastone Pansini, Luigi Pansini, Tobias Pantel, Nikolaos Pantelas, Konstantinos Papadopoulos, Vladimir Papic, Kee Park, Nick Park, Eric Homero Albuquerque Paschoal, Mylla Christie de Oliveira Paschoalino, Rajesh Pathi, Anilkumar Peethambaran, Thiago Andrade Pereira, Irene Panero Perez, Claudio José Piqueras Pérez, Tamilanandh Periyasamy, Stefano Peron, Michael Phillips, Sofía Sotos Picazo, Ertugrul Pinar, Daniel Pinggera, Rory Piper, Pathmanesan Pirakash, Branko Popadic, Jussi P. Posti, Rajmohan Bhanu Prabhakar, Sivanesalingam Pradeepan, Manjunath Prasad, Paola Calvachi Prieto, Ron Prince, Andrea Prontera, Eva Provaznikova, Danilo Quadros, Nezly Jadid Romero Quintero, Mahmood Qureshi, Happiness Rabiel, Gabriel Rada, Sivagnanam Ragavan, Jueria Rahman, Omar Ramadhan, Padma Ramaswamy, Sakina Rashid, Jagath Rathugamage, Tõnu Rätsep, Minna Rauhala, Asif Raza, Naga Raju Reddycherla, Linus Reen, Mohamed Refaat, Luca Regli, Haijun Ren, Antonio Ria, Thales Francisco Ribeiro, Alessandro Ricci, Romana Richterová, Florian Ringel, Faith Robertson, Catarina Mayrink Siqueira Cabral Rocha, Juvenal de Souza Rogério, Adan Anibal Romano, Sally Rothemeyer, Gail Rousseau Gail Rousseau, Ranette Roza, Kevin David Farelo Rueda, Raiza Ruiz, Malin Rundgren, Radoslaw Rzeplinski, Raj S.Chandran, Ramesh Andi Sadayandi, William Sage, André Norbert Josef Sagerer, Mustafa Sakar, Mohcine Salami, Danjuma Sale, Youssuf Saleh, Cristina Sánchez-Viguera, Saning'o Sandila, Ahmet Metin Sanli, Laura Santi, Antonio Santoro, Aieska Kellen Dantas Dos Santos, Samir Cezimbra dos Santos, Borja Sanz, Shabal Sapkota, Gopalakrishnan Sasidharan, Ibrahim Sasillo, Rajeev Satoskar, Ali Caner Sayar, Vignesh Sayee, Florian Scheichel, Felipe Lourenzon Schiavo, Alexander Schupper, Andreas Schwarz, Teresa Scott, Esther Seeberger, Claudionor Nogueira Costa Segundo, Anwar Sadat Seidu, Antonio Selfa, Nazan Has Selmi, Claudiya Selvarajah, Necmiye Şengel, Martin Seule, Luiz Severo, Purva Shah, Muhammad Shahzad, Thobekile Shangase, Mayur Sharma, Ehab Shiban, Emnet Shimber, Temitayo Shokunbi, Kaynat Siddiqui, Emily Sieg, Martin Siegemund, Shahidur Rahman Sikder, Ana Cristina Veiga Silva, Ana Silva, Pedro Alberto Silva, Deepinder Singh, Carly Skadden, Josef Skola, Eirini Skouteli, Pawel Słoniewski, Brandon Smith, Guirish Solanki, Davi Fontoura Solla, Davi Solla, Ozcan Sonmez, Müge Sönmez, Wai Cheong Soon, Roberto Stefini, Martin Nikolaus Stienen, Bogdan Stoica, Matthew Stovell, Maria Natalia Suarez, Alaa Sulaiman, Mazin Suliman, Adi Sulistyanto, Şeniz Sulubulut, Sandra Sungailaite, Madlen Surbeck, Tomasz Szmuda, Graziano Taddei, Abraham Tadele, Ahmed Saleh Ahmed Taher, Riikka Takala, Krishna Murthy Talari, Bih Huei Tan, Leonardo Tariciotti, Murad Tarmohamed, Oumayma Taroua, Emiliano Tatti, Olli Tenovuo, Sami Tetri, Poojan Thakkar, Nqobile Thango, Satish Kumar Thatikonda, Tuomo Thesleff, Claudius Thomé, Owen Thornton, Shelly Timmons, Eva Ercilio Timoteo, Campbell Tingate, Souhil Tliba, Christos Tolias, Emma Toman, Ivan Torres, Luis Torres, Youness Touissi, Musa Touray, Maria Pia Tropeano, Georgios Tsermoulas, Christos Tsitsipanis, Mehmet Erhan Turkoglu, Özhan Merzuk Uçkun, Jamie Ullman, Gheorghe Ungureanu, Sarah Urasa, Obaid Ur-Rehman, Muhammed Uysal, Antonios Vakis, Egils Valeinis, Vaishali Valluru, Debby Vannoy, Pablo Vargas, Phillipos Varotsis, Rahul Varshney, Atul Vats, Damjan Veljanoski, Sara Venturini, Abhijit Verma, Clara Villa, Genaro Villa, Sofia Villar, Erin Villard, Antonio Viruez, Stefanos Voglis, Petar Vulekovic, Saman Wadanamby, Katherine Wagner, Rebecca Walshe, Jan Walter, Marriam Waseem, Tony Whitworth, Ruwani Wijeyekoon, Adam Williams, Mark Wilson, Sein Win, Achmad Wahib Wahju Winarso, Abraão Wagner Pessoa Ximenes, Anurag Yadav, Dipak Yadav, Kamal Makram Yakoub, Ali Yalcinkaya, Guizhong Yan, Eesha Yaqoob, Carlos Yepes, Ayfer Nazmiye Yılmaz, Betelehem Yishak, Farhat Basheer Yousuf, Muhammad Zamzuri Zahari, Hussein Zakaria, Diego Zambonin, Luca Zavatto, Bassel Zebian, Anna Maria Zeitlberger, Furong Zhang, Fengwei Zheng, and Michal Ziga
- Subjects
casemix ,management ,mortality ,emergency neurosurgery ,traumatic brain injury ,prospective observational cohort study ,Neurology (clinical) - Abstract
© 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licenseBackground: Traumatic brain injury (TBI) is increasingly recognised as being responsible for a substantial proportion of the global burden of disease. Neurosurgical interventions are an important aspect of care for patients with TBI, but there is little epidemiological data available on this patient population. We aimed to characterise differences in casemix, management, and mortality of patients receiving emergency neurosurgery for TBI across different levels of human development. Methods: We did a prospective observational cohort study of consecutive patients with TBI undergoing emergency neurosurgery, in a convenience sample of hospitals identified by open invitation, through international and regional scientific societies and meetings, individual contacts, and social media. Patients receiving emergency neurosurgery for TBI in each hospital's 30-day study period were all eligible for inclusion, with the exception of patients undergoing insertion of an intracranial pressure monitor only, ventriculostomy placement only, or a procedure for drainage of a chronic subdural haematoma. The primary outcome was mortality at 14 days postoperatively (or last point of observation if the patient was discharged before this time point). Countries were stratified according to their Human Development Index (HDI)—a composite of life expectancy, education, and income measures—into very high HDI, high HDI, medium HDI, and low HDI tiers. Mixed effects logistic regression was used to examine the effect of HDI on mortality while accounting for and quantifying between-hospital and between-country variation. Findings: Our study included 1635 records from 159 hospitals in 57 countries, collected between Nov 1, 2018, and Jan 31, 2020. 328 (20%) records were from countries in the very high HDI tier, 539 (33%) from countries in the high HDI tier, 614 (38%) from countries in the medium HDI tier, and 154 (9%) from countries in the low HDI tier. The median age was 35 years (IQR 24–51), with the oldest patients in the very high HDI tier (median 54 years, IQR 34–69) and the youngest in the low HDI tier (median 28 years, IQR 20–38). The most common procedures were elevation of a depressed skull fracture in the low HDI tier (69 [45%]), evacuation of a supratentorial extradural haematoma in the medium HDI tier (189 [31%]) and high HDI tier (173 [32%]), and evacuation of a supratentorial acute subdural haematoma in the very high HDI tier (155 [47%]). Median time from injury to surgery was 13 h (IQR 6–32). Overall mortality was 18% (299 of 1635). After adjustment for casemix, the odds of mortality were greater in the medium HDI tier (odds ratio [OR] 2·84, 95% CI 1·55–5·2) and high HDI tier (2·26, 1·23–4·15), but not the low HDI tier (1·66, 0·61–4·46), relative to the very high HDI tier. There was significant between-hospital variation in mortality (median OR 2·04, 95% CI 1·17–2·49). Interpretation: Patients receiving emergency neurosurgery for TBI differed considerably in their admission characteristics and management across human development settings. Level of human development was associated with mortality. Substantial opportunities to improve care globally were identified, including reducing delays to surgery. Between-hospital variation in mortality suggests changes at an institutional level could influence outcome and comparative effectiveness research could identify best practices. Funding: National Institute for Health Research Global Health Research Group.
- Published
- 2022
26. Fulminant Myocarditis Following SARS-CoV-2 Infection
- Author
-
Saurabh Rajpal, Rami Kahwash, Matthew S. Tong, Kelly Paschke, Anjali A. Satoskar, Beth Foreman, Larry A. Allen, Nicole M. Bhave, Ty J. Gluckman, and Valentin Fuster
- Subjects
Cardiology and Cardiovascular Medicine - Abstract
A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygenation, ventricular arrhythmias, and pseudomonas bacteremia. She ultimately recovered and was discharged to home with normal left ventricular systolic function. Thereafter, she developed symptomatic ventricular tachycardia, for which she received an implantable cardioverter-defibrillator and antiarrhythmic drug therapy.
- Published
- 2022
27. Membranoproliferative Glomerulonephritis With Changing Immunofluorescence Pattern
- Author
-
Anjali A. Satoskar, Dalia Y. Ibrahim, Sergey V. Brodsky, Isabelle Ayoub, Tibor Nadasdy, and Brad H. Rovin
- Subjects
Nephrology - Published
- 2022
28. Detecting Attention Deficit Hyperactivity Disorder (ADHD) Inflicted Humans using Long Short-Term Memory (LSTM)
- Author
-
Prof. Jaya Jeswani, Priya Soni, Iqra Khatri, and Jatin Satoskar
- Abstract
Attention Deficit Hyperactivity Disorder (ADHD) is a common psychiatric disorder characterised by persistent patterns of inattention, hyperactivity, and impulsivity in children. The risk factor is that these children are frequently entangled in learning difficulties, which lead to frustration when they reach adulthood. This study uses functional Magnetic Resonance Imaging data for the resting-state brain to present an effective approach for ADHD identification at an early stage. The proposed method is based on seed correlation, which calculates the functional connectivity between seeds and all other voxels in the brain.This paper gives a walk through of the steps for using machine learning to analyse rs-fMRI data and, more specifically, to distinguish Attention Deficit Hyperactivity Disorder (ADHD) from healthy controls. I discuss (1) feature extraction with masks, (2) the advantages and disadvantages of long short term memory networks (LSTM) for classifying fMRI data, and (3) hypothesis testing and its application in model evaluation. Keywords: ADHD, f-MRI, Impulsive behaviour, Anxiety, LSTM
- Published
- 2022
29. Women Well-being Application
- Author
-
Iqra Khatri, Jyotsna More, Priya Soni, and Jatin Satoskar
- Abstract
Safety and security of girls is one of the most serious issues of our time; the crime rate is rapidly rising, and female wellbeing has become a greater concern than ever before in today's world. Many studies show that the majority of crimes occur late at night, but women are unable to shut themselves in from twilight till dawn. Women can't expect to work exclusively the day shift in metropolitan places, where offices, convenience stores, gas stations, and other businesses are open 24 hours a day, seven days a week. In the last five years, the use of smart phones with GPS navigation systems has risen significantly. So, if mobile phones are used for so many other purposes, why not women's security? As a result, a smart phone can be effectively employed for personal safety or a variety of other protection objectives, particularly for women. This application alerts the guardians with just a single click. SMS with the user's live location is sent to the preconfigured contact. An alarming siren goes on when the user activates the app. This application also enlists the nearby hospitals and police stations. As a result, this app has the potential to significantly assist in the rescue of women from dangerous situations. Keywords: Smartphone, Android, GPS (Global Positioning System), Alert Message, Panic Button, Safety Tips, Women Security
- Published
- 2022
30. Leishmaniasis: Biology, clinical diagnosis, and treatment
- Author
-
Mahmoud Al Saadi, Abhay R. Satoskar, and Bradford S. McGwire
- Published
- 2023
31. Contributors
- Author
-
Krishnendu Adhikary, Brenda Affinati, Amany M. Ahmed, Mahmoud Al Saadi, Alisar Alkutbi, Nizar A. Al-Shar’i, Waliza Ansar, Prachi Arora, Debasis Bagchi, Manashi Bagchi, Akshay M. Baheti, Vineet Baliga, Vishnu Bhat Ballambattu, Pradipta Banerjee, Priyanka Banerjee, Samudra Prosad Banik, Tejaswini Baral, Sanaa K. Bardaweel, Nicolas Barros, Pijush Basak, Bradford A. Becken, III, M. Bhagyalakshmi, Joyeeta Bhattacharya, Mohini Bhattacharya, Jhimli Bhattacharyya, Maitree Bhattacharyya, Ashmita Bhattacherjee, Karanam Sai Bhavya, Rinchen Doma Bhutia, Geetha Birudala, Ramadevi Birudala, Ayan Biswas, Nabendu Biswas, Sanchita Biswas, Shaoli Biswas, Pobitra Borah, Sayantan Bose, Fernando J. Bula Rudas, Subhendu Chakrabarty, Modhurima Chakraborti, Atreyee Chakraborty, Sanjoy Chakraborty, Shrabastee Chakraborty, Sudipta Chakraborty, S.B. Chandrasekar, Archana Chatterjee, Aritra Chatterjee, Gourab Chatterjee, Rituparna Chatterjee, Tanima Chatterjee, Rameshwar Nath Chaurasia, Bo-Kai Chen, Ashna Chettri, Hui-Fang Chiu, Antara Choudhury, Sailee Chowdhury, Sougata Roy Chowdhury, Courtney Collins, Elaine Colomb, M. Emilio Cuevas-Galindo, Amitava Das, Amlan Das, Arpita Das, Dibya Das, Mousumi Das, Pran Kishore Deb, Sujoy Deb, Anirban Debnath, Satyendra Deka, Shirley F. Delair, Alyssa Delia, Karishma Desai, S. Devaraja, Priyankar Dey, Karma Gurmey Dolma, Bernard William Downs, Jaclyn M. Downs, Lourdes Eguiguren, Mohamed S. El Masry, Elizabeth Estevez-Fregoso, Eunice D. Farfán-García, Zannatul Ferdous, Ramakrishnan Ganesan, Itzel H. García-Coronel, Jazmín García-Machorro, Roseline George, Nandini Ghosh, Rituparna Ghosh, Santanu Ghosh, Arunava Goswami, Karthik Gourishetti, Tanner Guith, Krishna Rao Gurugubelli, Dania Hassan, Sangeeta Hazarika, Vijay Hegde, Ashfaque Hossain, Sheikh Shah Hossain, Amanda L. Hurst, Anahita Jalilvand, Sasmita Jana, Junaid Jibran Jawed, Miguel Jorge, Sedat Kacar, Vikash Kansal, Nabanita Kar, Muhammad Manjurul Karim, Bidita Khandelwal, Ahmet Kilic, Prakash Koirala, Chandrashekhar Kubal, Abhai Kumar, Umesh Kumar, V. Kumar, Leena Kumari, Steve Kushner, Santiago M.C. Lopez, Maxima Madhu, Puja Maitra, Himangshu Sekhar Maji, Sushomasri Maji, Rajib Majumder, Labonya Mandal, Supriya Mandal, Bradford S. McGwire, Odete R. Mendes, Nagendra Babu Mennuru, Sonal Sekhar Miraj, Sutanuka Mitra, Jalal Moludi, Sandipan Mukherjee, Murali Munisamy, Krishna Murti, Monali NandyMazumdar, Masoud Nateqi, Kari A. Neemann, Andrew Nguyen, Aben Ovung, Kunal Pal, Anil T. Pawar, Prakash Narayanan Vasudevan Potty, Megha Rana, Mahadev Rao, Sayantan Ray, Jayati Ray Dutta, Zachary P. Rokop, Sashwati Roy, Brenda A. Rubio-Velazquez, Abinit Saha, Rudra P. Saha, Tiyas Saha, Saptadip Samanta, Saptarshi Sanyal, Dipayan Sarkar, Dipika Sarkar, Riya Sarkar, Alice I. Sato, Abhay R. Satoskar, Abhishek Kumar Sen, Chandan K. Sen, Pracheta Sengupta, Aditi Shah, Dikshya Sharma, Pottathil Shinu, H.N. Shivaprasad, B. Shrikar Reddy, Moumita Sil, Abhilasha Singh, Kanhaiya Singh, Manoj Kumar Singh, Smita Singh, Varun Kumar Singh, N.V.L. Sirisha Mulukuri, Jessica Smith, Marvin A. Soriano-Ursúa, Shruthi Srinivas, Shahnaz Sultana, Arindam Talukdar, Pranathi Tata, Levin Thomas, Jose G. Trujillo-Ferrara, Md. Hafiz Uddin, Muralidhar Varma, Meera Varman, Katharigatta N. Venugopala, Priyanka Verma, Shashidhar Vishwanath, Navya Vyas, Chin-Kun Wang, Jon Wisler, and Nilesh Yadav
- Published
- 2023
32. Editorial: Regulation of the host’s immune system by parasitic infections and its implications
- Author
-
Martha, Legorreta-Herrera, Miriam, Rodriguez-Sosa, and Abhay R, Satoskar
- Subjects
Microbiology (medical) ,Infectious Diseases ,Immunology ,Microbiology - Published
- 2022
33. Essential Role of Neutrophils in the Protective Immune Response Induced by a Live Attenuated Leishmania Vaccine
- Author
-
John Philip McCoy, Sreenivas Gannavaram, Nevien Ismail, Subir Karmakar, Kazuyo Takeda, Sanika Satoskar, Ankit Saxena, Silvia De Paoli, Pradeep K. Dagur, Hira L. Nakhasi, Ranadhir Dey, Parna Bhattacharya, and Monika Satoskar
- Subjects
Adoptive cell transfer ,Neutrophils ,T cell ,Immunology ,Leishmania donovani ,Lymphocyte Activation ,Vaccines, Attenuated ,Article ,Proinflammatory cytokine ,Mice ,Immune system ,medicine ,Animals ,Immunology and Allergy ,Leishmaniasis Vaccines ,biology ,Th1 Cells ,Leishmania ,biology.organism_classification ,medicine.disease ,Visceral leishmaniasis ,medicine.anatomical_structure ,Neutrophil Infiltration ,Leishmaniasis, Visceral ,Female ,Ex vivo - Abstract
No licensed vaccine exists against visceral leishmaniasis (VL), a disease caused by the Leishmania donovani parasite. We have previously reported both macrophages and dendritic cells play important role in the protection induced by a live attenuated centrin gene–deleted L. donovani (LdCen−/−) parasite vaccine. The role of neutrophils in orchestrating the initial innate response to pathogens is widely recognized. To investigate the early interaction of LdCen−/− with neutrophils, we immunized mice intradermally in the ear pinna with LdCen−/−. Compared with LdWT infection, LdCen−/− parasites induced higher recruitment of neutrophils to the ear dermis and ear draining lymph nodes (dLN) as early as 6–18 h after immunization, which were predominantly proinflammatory in nature. Neutrophils from ear dLN of LdCen−/−-immunized mice exhibited heightened expression of costimulatory molecules and attenuated expression of coinhibitory molecules necessary for higher T cell activation. Further phenotypic characterization revealed heterogeneous neutrophil populations containing Nα and Nβ subtypes in the ear dLN. Of the two, the parasitized Nα subset from LdCen−/−-immunized mice exhibited much stronger Ag-specific CD4+ T cell proliferation ex vivo. Adoptive transfer of neutrophils bearing LdCen−/− parasites induced an increased Th1 response in naive mice. Importantly, neutrophil depletion significantly abrogated Ag-specific CD4+ T cell proliferation in LdCen−/−-immunized mice and impaired protection against virulent challenge. Conversely, replenishing of neutrophils significantly restored the LdCen−/− -induced host-protective response. These results suggest that neutrophils are indispensable for protective immunity induced by LdCen−/− parasite vaccine.
- Published
- 2020
34. Approach to a Woman with Sexual Assault
- Author
-
Danny H. Laliwala and Purnima Satoskar
- Subjects
Short Commentary ,medicine.medical_specialty ,business.industry ,medicine ,Obstetrics and Gynecology ,Psychiatry ,business ,Sexual assault - Abstract
Examination of a survivor of sexual assault should be performed meticulously. The aim is to confirm whether penetration occurred, document injuries and collect evidence to bring perpetrators to justice. First aid, contraception, preventive measures for Sexually Transmitted diseases and psychological support should be given to the survivor.
- Published
- 2021
35. Risk factors for bleeding hepatocellular adenoma in a United States cohort
- Author
-
Emily Winslow, Rohit Satoskar, Coleman Smith, Reena Jha, Stephen Fernandez, Marco Ertreo, Jimin Ko, Thomas M. Fishbein, Chelsea Mcdermott, Sameer Desale, and Christine Hsu
- Subjects
medicine.medical_specialty ,Carcinoma, Hepatocellular ,Malignancy ,Gastroenterology ,Adenoma, Liver Cell ,Vascularity ,Risk Factors ,Internal medicine ,medicine ,Humans ,Hedgehog Proteins ,Pathological ,Retrospective Studies ,Hepatology ,business.industry ,Liver Neoplasms ,Focal nodular hyperplasia ,Hepatocellular adenoma ,medicine.disease ,Magnetic Resonance Imaging ,United States ,Exact test ,Cohort ,medicine.symptom ,Steatosis ,business - Abstract
Known risk factors for hepatocellular adenoma (HCA) bleeding are size5 cm, growth rate, visible vascularity, exophytic lesions, β-catenin and Sonic Hedgehog activated HCAs. Most studies are based on European cohorts. The objective of this study is to identify additional risk factors for HCA bleeding in a US cohort.Retrospective chart review was performed on patients diagnosed with HCA on magnetic resonance imaging (n = 184) at an academic tertiary institution. Clinical, pathological, and imaging data were collected. Primary outcomes measured were HCA bleeding and malignancy. Statistical analysis was performed with SAS 9.4 using Chi-Square, Fisher's exact test, sample t test, non-parametric Wilcoxon test, and logistic regression.After excluding patients whose pathology showed focal nodular hyperplasia and non-adenoma lesions, follow-up data were available for 167 patients. 16% experienced microscopic or macroscopic bleeding and 1.2% had malignancy. HCA size predicted bleeding (P .0001) and no patients with lesion size1.8 cm bled. In unadjusted analysis, hepatic adenomatosis (≥10 lesions) trended towards 2.8-fold increased risk of bleeding. Of patients with a single lesion that bled, 77% bled from a lesion5 cm. In patients with multiple HCAs that bled, 50% bled from lesions5 cm. In patients with multiple adenomas, size (P = .001) independently predicted bleeding and hepatic steatosis trended towards increased risk of bleeding (P = .05).In a large US cohort, size predicted increased risk of HCA bleeding while hepatic adenomatosis trended towards increased risk of bleeding. In patients with multiple HCAs, size predicted bleeding and hepatic steatosis trended toward increased risk of bleeding.
- Published
- 2021
36. Can Antinuclear Antibodies (ANA) be Monoclonal?
- Author
-
Brad H. Rovin, Laura Biederman, Mohankumar Doraiswamy, Anjali A. Satoskar, Samir V. Parikh, Brian Mussio, Sergey V. Brodsky, and Galina Mikhalina
- Subjects
Pathology ,medicine.medical_specialty ,Anti-nuclear antibody ,medicine.diagnostic_test ,biology ,business.industry ,Immunofluorescence ,Stain ,Diseases of the genitourinary system. Urology ,Subclass ,Staining ,Nephrology ,Polyclonal antibodies ,mental disorders ,Biopsy ,Monoclonal ,medicine ,biology.protein ,Case Series ,RC870-923 ,business ,psychological phenomena and processes - Abstract
Background. Nuclear staining by immunofluorescence in a kidney biopsy is often seen in patients with positive antinuclear antibodies (ANA) in the serum. These ANA are usually polyclonal, but herein we report 9 cases with an unusual finding of monoclonal nuclear staining by immunofluorescence on kidney biopsy. Case Presentation. Nine cases with predominant stain for kappa or lambda light chain were identified by searching the renal pathology laboratory database for the past 10 years. All cases had positive stain for only kappa (six cases) or lambda (three cases) light chain in the nuclei. Eight out of nine cases had positive nuclear IgG stain, and one case had positive nuclear IgA stain. Among cases with positive nuclear IgG staining, six cases were positive for IgG1 subclass, one case was positive for IgG2 subclass, and one case was positive for IgG3 subclass. All patients with positive IgG nuclear stain, who had testing for ANA, had positive ANA. Patients with positive IgG1 subclass did not have monoclonal protein in the serum or urine, but the patient with positive IgG2 subclass and lambda light chain stain in the nuclei had IgG lambda monoclonal gammopathy. Conclusions. We identified a new unique pattern of nuclear stain by immunofluorescence in kidney biopsies that suggests the presence of monoclonal ANA. Workup for underlying monoclonal gammopathy is warranted in such patients.
- Published
- 2021
37. From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection
- Author
-
Abhay R. Satoskar, Thalia Pacheco-Fernández, Greta Volpedo, Sreenivas Gannavaram, Ryan H Huston, Parna Bhattacharya, Erin A Holcomb, and Hira L. Nakhasi
- Subjects
Pharmacology ,medicine.medical_specialty ,Poverty ,business.industry ,Public health ,Vaccination ,Immunology ,Leishmaniasis ,medicine.disease ,Clinical trial ,Environmental health ,Parasitic disease ,Vaccine Development ,Drug Discovery ,Health care ,medicine ,Neglected tropical diseases ,Humans ,Molecular Medicine ,business ,Leishmaniasis Vaccines - Abstract
INTRODUCTION Leishmaniasis is a major public health problem and the second most lethal parasitic disease in the world due to the lack of effective treatments and vaccines. Even when not lethal, leishmaniasis significantly affects individuals and communities through life-long disabilities, psycho-sociological trauma, poverty, and gender disparity in treatment. AREAS COVERED This review discusses the most relevant and recent research available on Pubmed and GoogleScholar highlighting leishmaniasis' global impact, pathogenesis, treatment options, and lack of effective control strategies. An effective vaccine is necessary to prevent morbidity and mortality, lower health care costs, and reduce the economic burden of leishmaniasis for endemic low- and middle-income countries. Since there are several forms of leishmaniasis, a pan-Leishmania vaccine without geographical restrictions is needed. This review also focuses on recent advances and common challenges in developing prophylactic strategies against leishmaniasis. EXPERT OPINION Despite advances in pre-clinical vaccine research, approval of a human leishmaniasis vaccine still faces major challenges - including manufacturing of candidate vaccines under Good Manufacturing Practices, developing well-designed clinical trials suitable in endemic countries, and defined correlates of protection. In addition, there is a need to explore Challenge Human Infection Model to avoid large trials because of fluctuating incidence and prevalence of leishmanasis.
- Published
- 2021
38. Glomerular crescents, IgA-deposits, ANCA, infection – unravelling the diagnostic conundrum
- Author
-
Mineaki Kitamura, Salem Almaani, Bindu Challa, Mohankumar Doraiswamy, Isabelle Ayoub, Laura Biederman, Samir V. Parikh, Ana Molovic-Kokovic, Jason Benedict, Nilesh Mhaskar, Zeid Khitan, Sergey V. Brodsky, Tibor Nadasdy, and Anjali A Satoskar
- Abstract
IntroductionGlomerulonephritis (GN) with crescents and IgA deposits on kidney biopsy poses a frequent diagnostic and therapeutic dilemma because of multiple possibilities.MethodsNative kidney biopsies showing IgA deposition and crescents (excluding lupus nephritis) were identified from our biopsy archives between January 2010 and December 2021. Detailed clinico-pathologic features were assessed. One-year clinical follow-up on a subset of cases was performed.ResultsA total of 285 cases were identified and these clustered into IgA nephropathy (IgAN, n=108), Staphylococcus or other infection-associated-GN (SAGN/IRGN, n=46), and anti-neutrophil cytoplasmic antibody associated-GN (ANCA-GN, n=24) based on constellation of clinico-pathologic features, but 101 cases (Group X) could not be definitively differentiated. The reasons have been elucidated, most important being atypical combination of clinico-pathologic features and lack of definitive evidence of active infection. Follow-up (on 72/101 cases), revealed that clinicians’ working diagnosis was IgAN in 42%, SAGN/IRGN in 24%, ANCA-GN in 24%, and others in 7% of the cases, but treatment approach varied from supportive/antibiotics to immunosuppression in each subgroup. Comparing these cases as “received immunosuppression” versus “no-immunosuppression”, only two features - C3-dominant staining; and possibility of recent infection differed (higher in the no-immunosuppression group [pConclusionDiagnostic overlap may remain unresolved in a substantial number of kidney biopsies with glomerular crescents and IgA deposits. A case-by-case approach, appropriate antibiotics if infection is ongoing, and consideration for cautious immunosuppressive treatment for progressive renal dysfunction may be needed for best chance of renal recovery.
- Published
- 2022
39. Leishmania major centrinknock-out parasites alter the kynurenine- aryl hydrocarbon receptor signaling to produce a pro-inflammatory response
- Author
-
Timur Oljuskin, Nazli Azodi, Greta Volpedo, Parna Bhattacharya, Nevien Ismail, Shinjiro Hamano, Greg Matlashewski, Abhay R. Satoskar, Sreenivas Gannavaram, and Hira L. Nakhasi
- Abstract
SummaryLeishmaniasis is a parasitic disease that is prevalent in approximately 88 countries, and yet no licensed human vaccine exists against it. Towards control of leishmaniasis, we have developedLeishmania major centringene deletion mutant strains (LmCen-/-) as a live attenuated vaccine, which induces a strong Th1 response to provide IFN-γ-mediated protection to the host. However, the immune mechanisms of such protection remain to be understood. Metabolomic reprogramming of the host cells followingLeishmania-infection has been shown to play a critical role in pathogenicity and shaping the immune response following infection. Here, we applied untargeted mass spectrometric analysis to study the metabolic changes induced by infection withLmCen-/-and compared those with virulentL. majorparasite infection to identify the immune mechanism of protection. Our data shows that immunization withLmCen-/-parasites, in contrast to virulentL. majorinfection, alters tryptophan metabolism to down-regulate kynurenine-AhR signaling and promote a pro-inflammatory response.
- Published
- 2022
40. Leishmania mexicana Centrin Knock out Parasites Promote M1-polarizing Metabolic Changes
- Author
-
Greta Volpedo, Timur Oljuskin, Nazli Azodi, Shinjiro Hamano, Greg Matlashewski, Sreenivas Gannavaram, Hira L. Nakhasi, and Abhay R. Satoskar
- Abstract
Leishmaniasis is a tropical disease present in more than 90 countries. Presently, there is no approved vaccine for human use. We have previously developed live attenuated L. mexicana Cen−/− (LmexCen−/−) as a vaccine candidate that showed excellent efficacy that was characterized by reduced activation of Th2 responses and enhanced Th1 responses, contrary to wild type L. mexicana (LmexWT) infection. Towards understanding the interplay between immune mechanisms of protection and metabolic reprogramming, we applied untargeted mass spectrometric analysis to LmexCen−/− and compared them with LmexWT infection. Data showed that enriched pentose phosphate pathway (PPP) in ears immunized with LmexCen−/− parasites, compared to naïve and LmexWT-infected ears. This pathway is known to promote an M1 phenotype in macrophages, suggesting a switch to a pro-inflammatory phenotype following LmexCen−/− inoculation. Accordingly, inhibition of the PPP in macrophages cultured with LmexCen−/− parasites led to diminished production of nitric oxide, IL-12, and IL-1β, hallmarks of classical activation. Overall, our study revealed novel immune regulatory mechanisms that may be critical for the induction of protective immunity.
- Published
- 2022
41. Integrated immune monitoring of HCMV infection in pregnant women with complications and its association with adverse pregnancy outcomes
- Author
-
Harsha Chandrashekhar Palav, Gauri Bhonde, Varsha Padwal, Shilpa Velhal, Jacintha Pereira, Amit Kumar Singh, Sayantani Ghosh, Kalyani Karandikar, Purnima Satoskar, Vikrant Bhor, and Vainav Patel
- Subjects
Infectious Diseases ,Microbiology - Published
- 2023
42. Pentalinonsterol, a Phytosterol from Pentalinon andrieuxii, is Immunomodulatory through Phospholipase A2 in Macrophages toward its Antileishmanial Action
- Author
-
Gaurav Gupta, Sanjay Varikuti, Thomas J. Hund, Abhay R. Satoskar, Sainath R. Kotha, Andrew B. Shelton, Travis O. Gurney, Narasimham L. Parinandi, Nidhi Srivastava, A. Douglas Kinghorn, and James R. Fuchs
- Subjects
biology ,Chemistry ,medicine.medical_treatment ,Biophysics ,Cell Biology ,General Medicine ,Pharmacology ,Leishmania ,biology.organism_classification ,Biochemistry ,In vitro ,Proinflammatory cytokine ,chemistry.chemical_compound ,Cytokine ,Phospholipase A2 ,In vivo ,medicine ,biology.protein ,Macrophage ,Arachidonic acid - Abstract
Our earlier in vitro and in vivo studies have revealed that the phytosterol, pentalinonsterol (cholest-4,20,24-trien-3-one) (PEN), isolated from the roots of Pentalinon andrieuxii, possesss immunomodulatory properties in macrophages and dendritic cells. Leishmaniasis, caused by the infection of Leishmania spp. (a protozoan parasite), is emerging as the second-leading cause of mortality among the tropical diseases and there is an unmet need for a pharmacological intervention of leishmaniasis. Given the beneficial immunomodulatory actions and lipophilic properties of PEN, the objective of this study was to elucidate the mechanism(s) of action of the immunomodulatory action(s) of PEN in macrophages through the modulation of phospholipase A2 (PLA2) activity that might be crucial in the antileishmanial action of PEN. Therefore, in this study, we investigated whether PEN would modulate the activity of PLA2 in RAW 264.7 macrophages and mouse bone marrow-derived primary macrophages (BMDMs) in vitro and further determined how the upstream PLA2 activation would regulate the downstream cytokine release in the macrophages. Our current results demonstrated that (i) PEN induced PLA2 activation (arachidonic acid release) in a dose- and time-dependent manner that was regulated upstream by the mitogen-activated protein kinases (MAPKs); (ii) the PEN-induced activation of PLA2 was attenuated by the cPLA2-specific pharmacological inhibitors; and (iii) the cPLA2-specific pharmacological inhibitors attenuated the release of inflammatory cytokines from the macrophages. For the first time, our current study demonstrated that PEN exhibited its immunomodulatory actions through the activation of cPLA2 in the macrophages, which potentially could be used in the development of a pharmacological intervention against leishmaniasis.
- Published
- 2021
43. Pre-Operative Cardiovascular Testing before Liver Transplantation
- Author
-
Itsik Ben-Dor, Charan Yerasi, Toby Rogers, Brian J. Forrestal, Brian C. Case, Hayder Hashim, Ron Waksman, Rohit Satoskar, Alexander Lalos, Syed Z. Qamer, Michael Yang, Giorgio A. Medranda, Chava Chezar-Azerrad, Nelson L. Bernardo, Lowell F. Satler, and Sant Kumar
- Subjects
Adult ,Male ,Cardiac Catheterization ,medicine.medical_specialty ,Computed Tomography Angiography ,medicine.medical_treatment ,Myocardial Infarction ,030204 cardiovascular system & hematology ,Liver transplantation ,Coronary Angiography ,Revascularization ,End Stage Liver Disease ,Coronary artery disease ,03 medical and health sciences ,Liver disease ,Postoperative Complications ,0302 clinical medicine ,Internal medicine ,Preoperative Care ,Myocardial Revascularization ,medicine ,Humans ,Myocardial infarction ,Mortality ,Non-ST Elevated Myocardial Infarction ,Aged ,Retrospective Studies ,Cardiac catheterization ,business.industry ,Myocardial Perfusion Imaging ,Middle Aged ,medicine.disease ,Liver Transplantation ,Transplantation ,Cardiovascular Diseases ,Echocardiography ,Exercise Test ,Cardiology ,ST Elevation Myocardial Infarction ,Female ,030211 gastroenterology & hepatology ,Transthoracic echocardiogram ,Cardiology and Cardiovascular Medicine ,business - Abstract
End-stage liver disease (ESLD) is increasingly prevalent and shares many risk factors with coronary artery disease (CAD). No specific guidelines exist for pre-liver transplant evaluation of CAD, and pretransplant cardiovascular testing varies widely. The aim of this study is to characterize pre-transplant cardiac testing practices with post-transplant clinical outcomes. We retrospectively reviewed patients undergoing initial liver transplantation at our transplant center between January 2015 and March 2019. Patients with previous liver transplantation or multi-organ transplantation were excluded. Electronic medical records were reviewed for relevant demographic and clinical data. We included 285 patients with a mean follow-up of 2.4 years. Of 274 patients (96.1%) with pre-transplant transthoracic echocardiogram (TTE), 18 (6.6%) were abnormal. Non-invasive ischemic testing was performed in 193 (68%) patients: 165 (58%) underwent stress TTE, 24 (8%) underwent myocardial perfusion imaging, 3 underwent coronary computed tomography, and 1 underwent exercise electrocardiogram. Sixteen patients (6%) had left heart catheterization of which 10 (63%) were abnormal and 5 proceeded to revascularization before transplant. There were 4 (1.4%) deaths within 30 days of transplant and 23 deaths (8.1%) in total. ST-elevation myocardial infarction was seen in 1 patient within 30 days and 1 patient after 30 days (0.7% total). No cardiovascular deaths were observed. Among patients undergoing liver transplantation, pre-transplantation cardiovascular testing is exceedingly common and post-transplant cardiovascular complications are rare. Additional research is needed to determine the optimal testing and surveillance in this patient population.
- Published
- 2021
44. Hypertension and the Kidney: Reduced Kidney Mass Is Bad for Both Normotensive and Hypertensive Rats
- Author
-
Rachel T Scarl, Min Xiao, Lee Hebert, Laura Biederman, Sergey V. Brodsky, Iouri Ivanov, Kyle Ware, Anjali A. Satoskar, Vedat O. Yildiz, Jessica Hemminger, and Ajay Medipally
- Subjects
medicine.medical_specialty ,Original Contributions ,medicine.medical_treatment ,030232 urology & nephrology ,Urology ,Renal function ,Blood Pressure ,030204 cardiovascular system & hematology ,Kidney ,Rats, Inbred WKY ,Nephropathy ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Rats, Inbred SHR ,Internal Medicine ,Animals ,Medicine ,Hematuria ,Creatinine ,Proteinuria ,business.industry ,medicine.disease ,Nephrectomy ,Rats ,medicine.anatomical_structure ,Blood pressure ,chemistry ,Hypertension ,bcl-Associated Death Protein ,medicine.symptom ,business ,Kidney disease - Abstract
BACKGROUND Hypertension is a leading cause of chronic kidney disease worldwide. Early studies demonstrated the short-term effects of hypertension on kidney function and morphology in ablative nephropathy. The aim of this study was to investigate the long-term consequences of hypertension in 5/6 nephrectomy (5/6NE) model. METHODS Reduction of the kidney mass by 5/6NE was created in spontaneous hypertensive rats (SHR) and genetically similar normotensive Wistar Kyoto (WKY) rats. Blood pressure, serum creatinine (SCr), hematuria, and proteinuria were monitored weekly for 23 weeks. Kidney morphology was assessed at the end of the study. Sham-operated rats from both strains were used as controls. RESULTS Rats with 5/6NE had increased SCr, blood pressure, hematuria, and proteinuria in both SHR and WKY. Even though the SCr levels and blood pressure were greater in 5/6NE SHR as compared with 5/6NE WKY rats, absolute changes from sham-operated rats were not statistically significant between these 2 groups. 5/6NE SHR had earlier onset and higher proteinuria than 5/6NE WKY rats. Hematuria was similar in 5/6NE SHR and 5/6NE WKY rats. However, 5/6NE SHR had enlarged glomeruli, increased interstitial fibrosis, and prominent intimal thickening in the small arteries/arterioles as compared with 5/6NE WKY rats. CONCLUSIONS The long-term severity of kidney injury correlated with higher blood pressure. Reduction of the kidney mass increases SCr, hematuria, proteinuria, and blood pressure in both normotensive and hypertensive rats. Histological assessment provides better information about underlying chronic kidney injury than actual changes in SCr and urinalysis.
- Published
- 2021
45. Robotic-assisted hiatal hernia repair and pulmonary embolism: an institution-based retrospective cohort study
- Author
-
Aanuoluwapo Obisesan, Savni Satoskar, and Vinay Singhal
- Subjects
Adult ,Male ,medicine.medical_specialty ,Esophageal hiatus ,030232 urology & nephrology ,Health Informatics ,Hiatal hernia ,03 medical and health sciences ,0302 clinical medicine ,Robotic Surgical Procedures ,medicine ,Humans ,Herniorrhaphy ,Retrospective Studies ,business.industry ,Retrospective cohort study ,Guideline ,Middle Aged ,medicine.disease ,Surgery ,Pulmonary embolism ,Hernia, Hiatal ,Treatment Outcome ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Cohort ,Chemoprophylaxis ,Laparoscopy ,Pulmonary Embolism ,business ,Complication - Abstract
Hiatal hernia (HH) is an abnormal protrusion of components of the abdominal viscera through the esophageal hiatus. The laparoscopic approach is the gold standard for repair with the robotic technique now gaining wide acceptance. Pulmonary embolism (PE) is a well-known post-operative complication but its incidence following robotically assisted HH repairs is not well known. This study provides a descriptive analysis of three patients who developed PE after robotic repairs of their HHs. The incidence of PE in the studied cohort was 2.7% (3 of 112) with a male preponderance (66.7%). The mean age of the patients was 55.3 years with a mean BMI of 32.2 kg/m2. The average duration of surgery was 4.2 h with sizes of the diaphragmatic defects ranging from 3 to 6 cm. Confirmatory PE diagnosis was made with a chest CT angiogram and the mean length of hospital stay was 4 days. PE although rare, is a preventable cause of in-patient mortality and morbidity with implications on healthcare costs and hospital resource use. The Caprini model provides a guide to pre-operative patient risk stratification and PE prevention, and the patients in this study were in the moderate to high-risk groups. Risk factors common to all patients were: age > 40 years, BMI > 30 kg/m2 and duration of surgery > 2 h with one of the patients having a previous history of PE. There are no established PE chemoprophylaxis guidelines for robotic HH repairs and in this cohort, heparin was commenced 6–8 h post-operatively. Thus, there is a need for a consensus chemoprophylaxis guideline in this subset of surgical patients. PE following robotic HH repair is associated with prolonged hospital stay and increased healthcare costs. Guidelines for effective pre-operative chemoprophylaxis for these repairs are needed to optimize patient outcomes.
- Published
- 2021
46. Leishmania mexicanaPromotes Pain-reducing Metabolomic Reprogramming In Cutaneous Lesions
- Author
-
Greta Volpedo, Timur Oljuskin, Blake Cox, Yulian Mercado, Candice Askwith, Nazli Azodi, Sreenivas Gannavaram, Hira L. Nakhasi, and Abhay R. Satoskar
- Abstract
Cutaneous leishmaniasis (CL) is characterized by extensive skin lesions associated with an aggressive inflammatory reaction. Despite the extensive inflammation, CL lesions are usually painless, indicating thatLeishmaniainfection may trigger anti-nociceptive activities in the infected tissues. To this date, the molecular mechanisms responsible for this clinical phenomenon have not been identified. Through an untargeted metabolomic analysis by mass spectrometry, we found enriched anti-nociceptive metabolic pathways in mice infected withLeishmania(L.)mexicana.In particular, endogenous purines were elevated at the lesion site during chronic infection, as well asin vitroin infected macrophages, compared to non-infected mice. These purines have known anti-inflammatory and analgesic properties by acting through adenosine receptors and inhibiting transient receptor potential channels of the vanilloid subtype 1 (TRPV1). Additionally, purine metabolites can promote interleukin (IL)-10 production, with a subsequent decrease in inflammation and pain sensitivity. We also found arachidonic acid metabolism enriched in the ear lesions compared to the non-infected controls. Arachidonic acid is a metabolite of anandamide (AEA) and 2-arachidonoylglycerol (2-AG). These endocannabinoids act on cannabinoid receptors 1 and 2 and TRPV1 channels to exert anti-inflammatory and analgesic effects. Our study provides the first evidence of metabolic pathways upregulated duringL. mexicanainfection that may mediate anti-nociceptive effects experienced by CL patients and identifies macrophages as a source of these metabolites.Graphical abstractL. mexicanainfection promotes the production of purines, as well as endocannabinoid mediators, which could act on different channels of dorsal root ganglia neuron to inhibit nociception.
- Published
- 2022
47. Dual scRNA-Seq analysis reveals rare and uncommon parasitized cell populations in chronic L. donovani infection
- Author
-
Konstantinos Karagiannis, Sreenivas Gannavaram, Chaitenya Verma, Parna Bhattacharya, Hira L Nakhasi, and Abhay Satoskar
- Abstract
Although phagocytic cells are documented targets of Leishmania parasites, it is unclear whether these parasites can infect other cell types. In this study, we describe a computational approach that exploits scRNA-seq to simultaneously analyze the transcriptomic signatures of the host cell and to identify rare and uncommon cells that harbor Leishmania donovani in the spleen and bone marrow. Individual cells were annotated as parasitized based on the presence of L. donovani transcripts that were detected with high accuracy. This unbiased approach allowed identification of heterogenous parasitized cell populations that cannot be detected by conventional methods. Consistent with previous studies, analysis of spleen cells isolated from L. donovani infected mice revealed inflammatory monocytes as the dominant parasitized cells. In addition, megakaryocytes, basophils, and NK cells were found to be the rare cells infected in the spleen. Unexpectedly, hematopoietic stem cells (HSCs), not known to be phagocytic, were the dominant cells parasitized cell in the bone marrow. In addition, eosinophils, megakaryocytes, and basal cells were the rare bone marrow cells found to be infected. scRNA-seq analysis revealed known phagocytic receptors FcγR and CD93 are expressed on HSCs. In vitro studies using purified HSCs showed that these cells can phagocytize L. donovani. Parasitized HSCs were also detectable in the bone marrow of mouse infected with L donovani.. This unbiased dual scRNA-seq approach enables identification of rare and uncommon parasitized cells that could be involved in pathogenesis, persistence, and protective immunity. Further, such approach could be used to study pathogenesis of other infectious agents.
- Published
- 2022
48. Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis
- Author
-
Subir Karmakar, Greta Volpedo, Wen-Wei Zhang, Patrick Lypaczewski, Nevien Ismail, Fabiano Oliveira, James Oristian, Claudio Meneses, Sreenivas Gannavaram, Shaden Kamhawi, Shinjiro Hamano, Jesus G. Valenzuela, Greg Matlashewski, Abhay R Satoskar, Ranadhir Dey, and Hira L. Nakhasi
- Abstract
Leishmaniasis is one of the top neglected tropical diseases with significant morbidity and mortality in low and middle-income countries (LMIC). However, this disease is also spreading in the developed world. Currently, there is a lack of effective strategies to control this disease. Vaccination can be an effective measure to control leishmaniasis and has the potential to achieve disease elimination. Recently, we have generated centrin gene-deleted new world L. mexicana (LmexCen-/-) parasites using CRISPR/Cas9 and showed that they protect mice against a homologous L. mexicana infection that causes cutaneous disease. In this study, we tested whether LmexCen-/- parasites can also protect against visceral leishmaniasis caused by L. donovani in a hamster model. We show that immunization with LmexCen-/- parasites is safe and does not cause lesions. Furthermore, such immunization conferred protection against visceral leishmaniasis caused by a needle-initiated L. donovani challenge, as indicated by a significant reduction in the parasite burdens in the spleen and liver and lack of mortality. Similar control of parasite burden was also observed against a sand fly mediated L. donovani challenge. Importantly, immunization with LmexCen-/- down-regulated the Th2 response as indicated by a significant reduction in the anti-inflammatory cytokines such as IL-10 and IL-4 and increased pro-inflammatory cytokine IFN-γ resulting in higher IFN-γ/IL-10 and IFN-γ/IL4 ratios compared to non-immunized animals. This contrasts with our studies with L. major centrin deletion mutants that showed a dominant Th1 response compared to L. major wild-type infection suggesting the divergent mechanisms of protection in the two mutant parasites. LmexCen-/- immunization resulted in long-lasting protection against L. donovani infection. Further, since the efficacy of LmCen-/- has not been determined against Leishmania strains prevalent in the Americas, LmexCen-/- may be a viable alternative. Taken together, our study demonstrates that immunization with LmexCen-/- parasites is safe and efficacious against old world visceral leishmaniasis.
- Published
- 2022
49. MIF confers survival advantage to pancreatic CAFs by suppressing interferon pathway-induced p53-dependent apoptosis
- Author
-
Voddu Suresh, Pujarini Dash, Sujit Suklabaidya, Krushna Chandra Murmu, Prakash K. Sasmal, Gajendra M. Jogdand, Deepti Parida, Manisha Sethi, Biswajit Das, Debasish Mohapatra, Subha Saha, Punit Prasad, Abhay Satoskar, and Shantibhusan Senapati
- Subjects
Apoptosis ,Biochemistry ,Intramolecular Oxidoreductases ,Pancreatic Neoplasms ,Mice ,Cancer-Associated Fibroblasts ,Cell Movement ,Cell Line, Tumor ,Genetics ,Tumor Microenvironment ,Animals ,Humans ,Interferons ,Tumor Suppressor Protein p53 ,Molecular Biology ,Macrophage Migration-Inhibitory Factors ,Biotechnology ,Carcinoma, Pancreatic Ductal ,Cell Proliferation - Abstract
The presence of activated pancreatic stellate cells (PSCs) in the pancreatic ductal adenocarcinoma (PDAC) microenvironment plays a significant role in cancer progression. Macrophage migration inhibitory factor (MIF) is overexpressed in PDAC tissues and expressed by both cancer and stromal cells. The pathophysiological role of MIF in PDAC-associated fibroblasts or PSCs is yet to be elucidated. Here we report that the PSCs of mouse or cancer-associated fibroblast cells (CAFs) of human expresses MIF and its receptors, whose expression gets upregulated upon LPS or TNF-α stimulation. In vitro functional experiments showed that MIF significantly conferred a survival advantage to CAFs/PSCs upon growth factor deprivation. Genetic or pharmacological inhibition of MIF also corroborated these findings. Further, co-injection of mouse pancreatic cancer cells with PSCs isolated from Mif
- Published
- 2022
50. Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis
- Author
-
Subir Karmakar, Greta Volpedo, Wen-Wei Zhang, Patrick Lypaczewski, Nevien Ismail, Fabiano Oliveira, James Oristian, Claudio Meneses, Sreenivas Gannavaram, Shaden Kamhawi, Shinjiro Hamano, Jesus G. Valenzuela, Greg Matlashewski, Abhay R. Satoskar, Ranadhir Dey, and Hira L. Nakhasi
- Subjects
Pharmacology ,Infectious Diseases ,Immunology ,Pharmacology (medical) - Abstract
Leishmaniasis is one of the top neglected tropical diseases with significant morbidity and mortality in low and middle-income countries (LMIC). However, this disease is also spreading in the developed world. Currently, there is a lack of effective strategies to control this disease. Vaccination can be an effective measure to control leishmaniasis and has the potential to achieve disease elimination. Recently, we have generatedcentringene-deleted new worldL. mexicana(LmexCen−/−) parasites using CRISPR/Cas9 and showed that they protect mice against a homologousL. mexicanainfection that causes cutaneous disease. In this study, we tested whetherLmexCen−/−parasites can also protect against visceral leishmaniasis caused byL. donovaniin a hamster model. We showed that immunization withLmexCen−/−parasites is safe and does not cause lesions. Furthermore, such immunization conferred protection against visceral leishmaniasis caused by a needle-initiatedL. donovanichallenge, as indicated by a significant reduction in the parasite burdens in the spleen and liver as well as reduced mortality. Similar control of parasite burden was also observed against a sand fly mediatedL. donovanichallenge. Importantly, immunization withLmexCen−/−down-regulated the disease promoting cytokines IL-10 and IL-4 and increased pro-inflammatory cytokine IFN-γ resulting in higher IFN-γ/IL-10 and IFN-γ/IL4 ratios compared to non-immunized animals.LmexCen−/−immunization also resulted in long-lasting protection againstL. donovaniinfection. Taken together, our study demonstrates that immunization withLmexCen−/−parasites is safe and efficacious against the Old World visceral leishmaniasis.
- Published
- 2022
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.